Sandra Misale: Intercepting PDAC in High-risk Individuals by KRAS-Targeting Vaccine
Sandra Misale/mskcc.org

Sandra Misale: Intercepting PDAC in High-risk Individuals by KRAS-Targeting Vaccine

Sandra Misale, Assistant Professor at Johns Hopkins Medicine, shared on X:

RAS-Revolution Alert!

Amazing publication on Cancer Discovery by Dr. Neeha Zaidi, S. Daniel Haldar, MD, Dr. Elizabeth Jaffee and colleagues on intercepting PDAC in high risk individuals by KRAS-targeting Vaccine, out today!

‘It’s just the beginning'”

Title: First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts

Authors: S. Daniel Haldar, Amanda L. Huff, Hejia Henry. Wang, Zirui Zhu, Maureen Berg, Jiayun Lu, Nancy Sun, Elizabeth Abou Diwan, Hassan Sinan, Christopher J. Thoburn, Matthew Z. Guo, Takeichi Yoshida, Linda C. Chu, Anna K. Ferguson, Dimitrios N. Sidiropoulos, Luciane T. Kagohara, Won Jin. Ho, Katherine M. Bever, Marina Baretti, Mark Yarchoan, Daniel A. Laheru, Julie M. Nauroth, Amy M. Thomas, Hao Wang, Nilofer Saba. Azad, Michael G. Goggins, Elizabeth M. Jaffee, Neeha Zaidi

Read the article

Other articles about pancreatic cancer on OncoDaily.